KEWAUNEE SCIENTIFIC CORP /DE/
Business
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products including steel and wood casework, fume hoods, modular systems, workstations, and epoxy surfaces. The company also manufactures biological safety cabinets, CO2 incubators, ultralow freezers, and related laboratory equipment through its November 2024 acquisition of Nu Aire. Products are sold to pharmaceutical, biotechnology, research, educational, healthcare, and governmental customers primarily through direct purchase orders, dealers, international subsidiaries in Singapore and India, and a national distributor.
Summary from 10-K filed 2026-06-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2026 2026-04-30 | FY 2025 2025-04-30 | FY 2024 2024-04-30 | FY 2023 2023-04-30 | FY 2022 2022-04-30 |
|---|---|---|---|---|---|---|
| Net sales | 282 | 240 | 204 | 219 | 169 | |
| Cost of products sold | 202 | 172 | 152 | 184 | 145 | |
| Gross profit | 80 | 69 | 52 | 36 | 24 | |
| Operating expenses | 64 | 51 | 34 | 30 | 27 | |
| Operating earnings | 17 | 18 | 18 | 5 | −3 | |
| Other income, net | 880,000 | 240,000 | 814,000 | 939,000 | 400,000 | |
| Interest expense | −4 | −3 | −2 | — | — | |
| Total earnings before income tax expense | 14 | 15 | 13 | 4 | −2 | |
| Income tax expense | 3 | 3 | −6 | 3 | 4 | |
| Net earnings | 10 | 12 | 19 | 1 | −6 | |
| Less: net earnings attributable to the non-controlling interest | 847,000 | 178,000 | 304,000 | 621,000 | 123,000 | |
| Net earnings attributable to Kewaunee Scientific Corporation | 10 | 11 | 19 | 738,000 | −6 | |
| Basic (in usd per share) | 3.36 | 3.98 | 6.51 | 0.26 | −2.2 | |
| Diluted (in usd per share) | 3.22 | 3.83 | 6.38 | 0.25 | −2.2 | |
| Basic (in shares) | 3 | 3 | 3 | 3 | 3 | |
| Diluted (in shares) | 3 | 3 | 3 | 3 | 3 |
Consolidated Balance Sheet
| Concept | Trend | FY 2026 2026-04-30 | FY 2025 2025-04-30 | FY 2024 2024-04-30 | FY 2023 2023-04-30 | FY 2022 2022-04-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 10 | 15 | 23 | 8 | 4 | |
| Restricted cash | 2 | 2 | 3 | 6 | 2 | |
| Receivables, less allowance: $633 (2026); $530 (2025) | 59 | 62 | 45 | 46 | 41 | |
| Inventories | 31 | 33 | 21 | 22 | 24 | |
| Prepaid expenses and other current assets | 5 | 6 | 5 | 6 | 6 | |
| Total Current Assets | 105 | 118 | 97 | 88 | 92 | |
| Property, plant and equipment, net | 22 | 23 | 18 | 16 | 15 | |
| Right of use assets | 11 | 13 | 7 | 9 | 8 | |
| Deferred income taxes | 4 | 4 | 7 | 0 | — | |
| Intangible assets, net | 16 | 18 | 0 | — | — | |
| Goodwill | 13 | 12 | 0 | — | — | |
| Other assets | 7 | 6 | 5 | 5 | 5 | |
| Total Assets | 178 | 195 | 135 | 119 | 119 | |
| Short-term borrowings | 74,000 | 986,000 | 3 | 4 | 2 | |
| Current portion of financing liability | 867,000 | 788,000 | 713,000 | 642,000 | 575,000 | |
| Current portion of term loans | 5 | 3 | 0 | — | — | |
| Current portion of financing lease liabilities | 70,000 | 96,000 | 111,000 | 85,000 | 126,000 | |
| Current portion of operating lease liabilities | 4 | 3 | 2 | 2 | 1 | |
| Accounts payable | 22 | 27 | 23 | 24 | 27 | |
| Employee compensation and amounts withheld | 9 | 9 | 6 | 4 | 5 | |
| Deferred revenue | 4 | 6 | 4 | 4 | 4 | |
| Other accrued expenses | 3 | 3 | 1 | 2 | 3 | |
| Total Current Liabilities | 48 | 54 | 41 | 40 | 42 | |
| Long-term portion of financing liability | 26 | 27 | 27 | 28 | 29 | |
| Long-term portion of seller notes | 0 | 24 | 0 | — | — | |
| Long-term portion of term loans | 15 | 10 | 0 | — | — | |
| Long-term portion of financing lease liabilities | 282,000 | 149,000 | 235,000 | 148,000 | 228,000 | |
| Long-term portion of operating lease liabilities | 6 | 9 | 5 | 7 | 6 | |
| Accrued pension and deferred compensation costs | 5 | 4 | 3 | 4 | 4 | |
| Deferred income taxes | 913,000 | 1 | 1 | 943,000 | 428,000 | |
| Other non-current liabilities | 290,000 | 364,000 | 462,000 | 455,000 | 531,000 | |
| Total Liabilities | 101 | 128 | 79 | 80 | 83 | |
| Commitments and Contingencies (Note 12) | — | — | — | — | — | |
| Common stock | 7 | 7 | 7 | 7 | 7 | |
| Additional paid-in capital | 7 | 6 | 5 | 5 | 4 | |
| Retained earnings | 69 | 59 | 48 | 29 | 28 | |
| Accumulated other comprehensive loss | −5 | −4 | −3 | −3 | −4 | |
| Common stock in treasury, at cost: 103000 shares (2026); 103 shares (2025) | −4 | −4 | −2 | −53,000 | −53,000 | |
| Non-controlling interest | 2 | 2 | 1 | 1 | 486,000 | |
| Total Stockholders' Equity | 77 | 66 | 56 | 38 | 36 | |
| Total Liabilities and Stockholders' Equity | 178 | 195 | 135 | 119 | 119 | |
| Treasury stock, shares (in shares) | 103,000 | 103,000 | 70,000 | 3,000 | 3,000 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2026 2026-04-30 | FY 2025 2025-04-30 | FY 2024 2024-04-30 | FY 2023 2023-04-30 | FY 2022 2022-04-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 6 | 5 | 3 | — | — | |
| Provision for credit losses | 343,000 | 68,000 | 276,000 | 120,000 | 92,000 | |
| Stock based compensation expense | 2 | 1 | 1 | 886,000 | 729,000 | |
| Deferred income taxes | −20,000 | −2 | −7 | 516,000 | 120,000 | |
| "Accrued payment in kind (""PIK"") interest" | −935,000 | — | — | — | — | |
| "Accrued payment in kind (""PIK"") interest" | — | 935,000 | 0 | — | — | |
| Amortization of deferred financing costs | 567,000 | 218,000 | 0 | — | — | |
| Receivables | 3 | −7 | 741,000 | −5 | −8 | |
| Inventories | 2 | 3 | 1 | 2 | −7 | |
| Accounts payable and other accrued expenses | −5 | 583,000 | 691,000 | −6 | 12 | |
| Deferred revenue | −2 | 765,000 | 277,000 | 568,000 | 406,000 | |
| Other, net | 1 | 20,000 | 286,000 | −2 | −3 | |
| Net cash provided by operating activities | 19 | 15 | 20 | −4 | −8 | |
| Capital expenditures | −4 | −2 | −4 | −4 | −2 | |
| Purchase of business, net of cash acquired | 0 | −29 | 0 | — | — | |
| Net cash used in investing activities | −4 | −31 | −4 | −4 | −2 | |
| Dividends paid to non-controlling interest in subsidiaries | −339,000 | −261,000 | 0 | — | 0 | |
| Proceeds from short-term borrowings | 16 | 73 | 148 | 61 | 59 | |
| Repayments on short-term borrowings | −17 | −76 | −149 | −59 | −65 | |
| Payments on sale-leaseback financing transaction | −844,000 | −772,000 | −642,000 | −575,000 | 0 | |
| Proceeds from long-term lease obligations | 226,000 | 0 | 202,000 | — | — | |
| Payment of deferred financing costs | 0 | −1 | 0 | — | — | |
| Payments on long-term lease obligations | −119,000 | −101,000 | −88,000 | — | — | |
| Taxes paid related to net share settlement of equity awards | −671,000 | 0 | — | — | — | |
| Purchase of Treasury Stock | 0 | −2 | −2 | 0 | — | |
| Net cash (used in) provided by financing activities | −19 | 7 | −3 | 15 | 11 | |
| Effect of exchange rate changes on cash, net | −917,000 | −67,000 | −54,000 | −72,000 | −75,000 | |
| Decrease in Cash, Cash Equivalents and Restricted Cash | −6 | −9 | 12 | 7 | 1 | |
| Interest | 3 | 3 | 2 | 2 | 480,000 | |
| Income taxes | 4 | 4 | 6 | 3 | 1 | |
| Change in debt related to seller note | 0 | 23 | 0 | — | — | |
| Assets obtained under new operating leases | 2 | 1 | 200,000 | 4 | — | |
| Assets obtained under new finance leases | 230,000 | 6,000 | 204,000 | 0 | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is KEWAUNEE SCIENTIFIC CORP /DE/'s CIK number?
KEWAUNEE SCIENTIFIC CORP /DE/'s SEC CIK number is 0000055529 (55529). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find KEWAUNEE SCIENTIFIC CORP /DE/'s SEC filings?
All of KEWAUNEE SCIENTIFIC CORP /DE/'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did KEWAUNEE SCIENTIFIC CORP /DE/ last report earnings?
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) most recently filed an earnings 8-K with the SEC on Jun 23, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0000055529-26-000017). This is KEWAUNEE SCIENTIFIC CORP /DE/'s most recent earnings filing of record — not a forecast of its next earnings date.
What is KEWAUNEE SCIENTIFIC CORP /DE/'s most recent earnings 8-K?
KEWAUNEE SCIENTIFIC CORP /DE/'s latest earnings 8-K (Item 2.02) was filed Jun 23, 2026 under accession 0000055529-26-000017. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View KEWAUNEE SCIENTIFIC CORP /DE/'s latest earnings 8-K →
Look up any company's CIK number →